-+ 0.00%
-+ 0.00%
-+ 0.00%

3 Promising Penny Stocks To Consider In September 2026

Simply Wall St·09/18/2026 17:05:03
Listen to the news

The market remained flat over the last week, but over the past 12 months, it has risen by 12%, with earnings forecasted to grow by 17% annually. In light of these conditions, identifying stocks with strong balance sheets and solid fundamentals can be key to finding value. Penny stocks, often representing smaller or newer companies, continue to offer intriguing opportunities for growth at lower price points despite being a somewhat outdated term.

Underneath we present a selection of stocks filtered out by our screen.

Broadwind (BWEN)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Broadwind, Inc. manufactures and sells structures, equipment, and components for power generation, critical infrastructure, and specialized applications in the United States with a market cap of $94.16 million.

Operations: The company's revenue is derived from two main segments: Gearing, contributing $31.62 million, and Industrial Solutions, accounting for $39.65 million.

Market Cap: $94.16M

Broadwind, Inc., with a market cap of US$94.16 million, has shown resilience in the penny stock arena by achieving profitability and reducing its debt-to-equity ratio from 11.4% to 5% over five years. The company's seasoned management and board, combined with a strong balance sheet where short-term assets exceed liabilities, support its growth strategy through acquisitions. Despite recent volatility and low return on equity at 12.4%, Broadwind's operating cash flow covers debt well at 407.7%. Analysts forecast earnings growth of 16.99% annually, indicating potential for future expansion despite current challenges in covering interest payments adequately with EBIT.

BWEN Financial Position Analysis as at Sep 2026
BWEN Financial Position Analysis as at Sep 2026

Quantum-Si (QSI)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Quantum-Si is a life sciences company focused on developing a proprietary single-molecule detection platform for proteomics, enabling next-gen protein sequencing, with a market cap of $159.81 million.

Operations: Quantum-Si generates its revenue from the biotechnology startup segment, amounting to $1.61 million.

Market Cap: $159.81M

Quantum-Si, with a market cap of US$159.81 million, is navigating the penny stock landscape with its focus on next-gen protein sequencing. Despite being pre-revenue with only US$0.602 million in revenue for the first half of 2026, it has made significant strides by demonstrating sequencing of 18 amino acids using its Proteus instruments. The company faces challenges including a Nasdaq delisting notice due to low share price and recent insider selling but remains debt-free and has sufficient cash runway for over a year. Its management team is experienced, providing stability as it aims to achieve full amino acid detection soon.

QSI Revenue & Expenses Breakdown as at Sep 2026
QSI Revenue & Expenses Breakdown as at Sep 2026

Ceragon Networks (CRNT)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Ceragon Networks Ltd. offers wireless transport solutions for cellular operators and other wireless service providers across various global regions, with a market cap of $186.33 million.

Operations: The company generates revenue of $346.73 million from its Wireless Hauling Solutions segment.

Market Cap: $186.33M

Ceragon Networks, with a market cap of US$186.33 million, is making strides in the penny stock arena by securing strategic alliances and significant contracts. Recent earnings reveal a revenue increase to US$93.91 million for Q2 2026, though it remains unprofitable with a net loss of US$2.09 million. The company has successfully reduced its debt-to-equity ratio over five years and maintains more cash than total debt, showcasing financial prudence. Its involvement in the Post-Quantum Communications Consortium highlights its commitment to innovation in quantum-safe communications while strengthening relationships through long-term agreements with major operators globally.

CRNT Debt to Equity History and Analysis as at Sep 2026
CRNT Debt to Equity History and Analysis as at Sep 2026

Taking Advantage

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.